{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:12:20Z","timestamp":1769926340515,"version":"3.49.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.exer.2019.107894","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T19:11:44Z","timestamp":1576609904000},"page":"107894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Predictive genetics for AMD: Hype and hopes for genetics-based strategies for treatment and prevention"],"prefix":"10.1016","volume":"191","author":[{"given":"Michael B.","family":"Gorin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"daSilva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.107894_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2017.09.008","article-title":"Genetic polymorphisms of CFH and ARMS2 do not predict response to antioxidants and zinc in patients with age-related macular degeneration: independent statistical evaluations of data from the age-related eye disease study","volume":"125","author":"Assel","year":"2018","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib2","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2013.07.039","article-title":"CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration","volume":"120","author":"Awh","year":"2013","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib3","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.ophtha.2015.03.028","article-title":"Re: Chew et al.: genetic testing in persons with age-related macular degeneration and the use of AREDS supplements: to test or not to test? (Ophthalmology 2015;122:212-215)","volume":"122","author":"Awh","year":"2015","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib4","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1167\/iovs.06-0655","article-title":"Expanded genome scan in extended families with age-related macular degeneration","volume":"47","author":"Barral","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002091","article-title":"Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration","volume":"3","author":"Canter","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.107894_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/jcm4020304","article-title":"Association of OCT derived drusen measurements with AMD associated-genotypic SNPs in Amish population","volume":"4","author":"Chavali","year":"2015","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2019.107894_bib7","doi-asserted-by":"crossref","first-page":"14517","DOI":"10.1038\/srep14517","article-title":"Pharmacogenetics of complement factor H Y402H polymorphism and treatment of neovascular AMD with anti-VEGF agents: a meta-analysis","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2019.107894_bib8","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1073\/pnas.0912702107","article-title":"Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2019.107894_bib9","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1038\/ncomms7063","article-title":"New loci and coding variants confer risk for age-related macular degeneration in East Asians","volume":"6","author":"Cheng","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2019.107894_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ophtha.2014.10.012","article-title":"Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?","volume":"122","author":"Chew","year":"2015","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib11","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.ophtha.2014.05.008","article-title":"No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/ajcn\/86.4.1210","article-title":"Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the age-related eye disease study","volume":"86","author":"Chiu","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.exer.2019.107894_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ophtha.2018.09.045","article-title":"Increased high-density lipoprotein levels associated with age-related macular degeneration: evidence from the EYE-RISK and European eye epidemiology consortia","volume":"126","author":"Colijn","year":"2019","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib14","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ophtha.2018.12.024","article-title":"Rod-mediated dark adaptation as a suitable outcome for early and intermediate age-related macular degeneration","volume":"126","author":"Curcio","year":"2019","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib15","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1167\/iovs.10-6235","article-title":"Associations of complement factor H and smoking with early age-related macular degeneration: the ALIENOR study","volume":"52","author":"Delcourt","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.296.3.301","article-title":"Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration","volume":"296","author":"Despriet","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.exer.2019.107894_bib17","first-page":"285","article-title":"Analysis of rare variants in the CFH gene in patients with the cuticular drusen subtype of age-related macular degeneration","volume":"21","author":"Duvvari","year":"2015","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107894_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152047","article-title":"Whole exome sequencing in patients with the cuticular drusen subtype of age-related macular degeneration","volume":"11","author":"Duvvari","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.107894_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4614-3209-8_33","article-title":"Oxidized low-density-lipoprotein-induced injury in retinal pigment epithelium alters expression of the membrane complement regulatory factors CD46 and CD59 through exosomal and apoptotic bleb release","volume":"801","author":"Ebrahimi","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.exer.2019.107894_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.exer.2019.107894_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-6524-3_10","article-title":"Exosomal MicroRNA discovery in age-related macular degeneration","volume":"1509","author":"Elshelmani","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exer.2019.107894_bib22","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1111\/aos.13865","article-title":"Effect of mitochondrial haplogroups on ranibizumab response in neovascular age-related macular degeneration patients: a pilot study","volume":"97","author":"Esteban","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ejhg.2008.140","article-title":"Variation near complement factor I is associated with risk of advanced AMD","volume":"17","author":"Fagerness","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib24","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/ije\/dyx189","article-title":"HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomization","volume":"46","author":"Fan","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.exer.2019.107894_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.survophthal.2014.11.002","article-title":"Genetic predictive biomarkers of anti-VEGF treatment response in patients with neovascular age-related macular degeneration","volume":"60","author":"Fauser","year":"2015","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib26","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1167\/iovs.10-6827","article-title":"Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration","volume":"52","author":"Fauser","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ophtha.2015.10.029","article-title":"Reticular pseudodrusen and their association with age-related macular degeneration: the melbourne collaborative cohort study","volume":"123","author":"Finger","year":"2016","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2013.03.009","article-title":"Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration","volume":"59","author":"Finger","year":"2014","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib29","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.17-22874","article-title":"Characterization of rod function phenotypes across a range of age-related macular degeneration severities and subretinal drusenoid deposits","volume":"59","author":"Flynn","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ng.2578","article-title":"Seven new loci associated with age-related macular degeneration","volume":"45","author":"Fritsche","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molimm.2016.11.016","article-title":"The complement system in age-related macular degeneration: a review of rare genetic variants and implications for personalized treatment","volume":"84","author":"Geerlings","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.exer.2019.107894_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration","volume":"38","author":"Gold","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib34","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/jcm3041335","article-title":"Endophenotypes for age-related macular degeneration: extending our reach into the preclinical stages of disease","volume":"3","author":"Gorin","year":"2014","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2019.107894_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2019.1318","article-title":"Assessment of novel genome-wide significant gene loci and lesion growth in geographic atrophy secondary to age-related macular degeneration","author":"Grassmann","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.survophthal.2004.12.002","article-title":"HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?","volume":"50","author":"Guymer","year":"2005","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib37","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2019.107894_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/1479-7364-5-5-420","article-title":"Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration","volume":"5","author":"Hageman","year":"2011","journal-title":"Hum. Genom."},{"key":"10.1016\/j.exer.2019.107894_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/07853890601097030","article-title":"Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications","volume":"38","author":"Hageman","year":"2006","journal-title":"Ann. Med."},{"key":"10.1016\/j.exer.2019.107894_bib40","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.ophtha.2015.04.024","article-title":"VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy in age-related macular degeneration","volume":"122","author":"Hagstrom","year":"2015","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1167\/iovs.05-0116","article-title":"Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6","volume":"47","author":"Haines","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib42","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1038\/s41598-019-43144-3","article-title":"Genetic risk score has added value over initial clinical grading stage in predicting disease progression in age-related macular degeneration","volume":"9","author":"Heesterbeek","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2019.107894_bib43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archophthalmol.2011.141","article-title":"Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study","volume":"129","author":"Ho","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib44","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1167\/iovs.13-13684","article-title":"Rare complement factor H variant associated with age-related macular degeneration in the Amish","volume":"55","author":"Hoffman","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib45","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1097\/IAE.0b013e31824dadf1","article-title":"Genotype-phenotype associations in neovascular age-related macular degeneration","volume":"32","author":"Hogg","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.exer.2019.107894_bib46","first-page":"518","article-title":"Osmotic and hypoxic induction of the complement factor C9 in cultured human retinal pigment epithelial cells: regulation of VEGF and NLRP3 expression","volume":"24","author":"Hollborn","year":"2018","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107894_bib47","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/aos.13049","article-title":"Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis","volume":"94","author":"Hong","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib48","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1111\/aos.12822","article-title":"Rare CFH mutations and early-onset age-related macular degeneration","volume":"94","author":"Hughes","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib49","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1371\/journal.pmed.0040355","article-title":"Neovascular age-related macular degeneration risk based on CFH, LOC387715\/HTRA1, and smoking","volume":"4","author":"Hughes","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.exer.2019.107894_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/380912","article-title":"Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration","volume":"74","author":"Iyengar","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib51","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.ophtha.2015.08.002","article-title":"The incidence and progression of age-related macular degeneration over 15 Years: the blue mountains eye study","volume":"122","author":"Joachim","year":"2015","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib52","first-page":"3861","article-title":"Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels","volume":"24","author":"Kavanagh","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib53","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI86418","article-title":"VEGF regulates local inhibitory complement proteins in the eye and kidney","volume":"127","author":"Keir","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.exer.2019.107894_bib54","first-page":"57","article-title":"Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26","volume":"10","author":"Kenealy","year":"2004","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107894_bib55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/cge.13447","article-title":"Genetic screening for macular dystrophies in patients clinically diagnosed with dry age-related macular degeneration","volume":"94","author":"Kersten","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.exer.2019.107894_bib57","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1167\/iovs.10-6080","article-title":"Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD","volume":"52","author":"Kloeckener-Gruissem","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib58","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1167\/iovs.07-1145","article-title":"Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"49","author":"Kondo","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1167\/iovs.09-3850","article-title":"ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations","volume":"51","author":"Kortvely","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"15","key":"10.1016\/j.exer.2019.107894_bib60","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/hmg\/ddy178","article-title":"Functional analyses of rare genetic variants in complement component C9 identified in patients with age-related macular degeneration","volume":"27","author":"Kremlitzka","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib61","first-page":"114","article-title":"Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration","volume":"118","author":"Kubicka-Trzaska","year":"2016","journal-title":"Klin. Ocz."},{"key":"10.1016\/j.exer.2019.107894_bib62","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1167\/iovs.11-7815","article-title":"The effect of photo-oxidative stress and inflammatory cytokine on complement factor H expression in retinal pigment epithelial cells","volume":"52","author":"Lau","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030762","article-title":"Is retinal metabolic dysfunction at the center of the pathogenesis of age-related macular degeneration?","volume":"20","author":"Leveillard","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.exer.2019.107894_bib64","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ajo.2008.01.027","article-title":"Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration","volume":"145","author":"Lin","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib65","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jamaophthalmol.2018.2019","article-title":"Association of genetic variants with response to anti-vascular endothelial growth factor therapy in age-related macular degeneration","volume":"136","author":"Lores-Motta","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib66","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1089\/gtmb.2018.0110","article-title":"Association between complement factor C2\/C3\/CFB\/CFH polymorphisms and age-related macular degeneration: a meta-analysis","volume":"22","author":"Lu","year":"2018","journal-title":"Genet. Test. Mol. Biomark."},{"key":"10.1016\/j.exer.2019.107894_bib67","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.redox.2015.11.011","article-title":"Oxidative stress-induced premature senescence dysregulates VEGF and CFH expression in retinal pigment epithelial cells: implications for age-related macular degeneration","volume":"7","author":"Marazita","year":"2016","journal-title":"Redox. Biol."},{"key":"10.1016\/j.exer.2019.107894_bib68","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1167\/iovs.11-8709","article-title":"Relevance of complement factor H\u201a\u00c4\u00ecRelated 1 (CFHR1) genotypes in age-related macular degeneration","volume":"53","author":"Martinez-Barricarte","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib69","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2004.10.027","article-title":"The use of cholesterol-lowering medications and age-related macular degeneration","volume":"112","author":"McGwin","year":"2005","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ophtha.2016.09.007","article-title":"Associations between serum vitamin D and genetic variants in vitamin D pathways and age-related macular degeneration in the European eye study","volume":"124","author":"McKay","year":"2017","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000475995","article-title":"Association of the CFH Y402H polymorphism with the 1-year response of exudative AMD to intravitreal anti-VEGF treatment in the Brazilian population","volume":"61","author":"Medina","year":"2019","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2019.107894_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130816","article-title":"CFH Y402H and ARMS2 A69S polymorphisms and oral supplementation with docosahexaenoic acid in neovascular age-related macular degeneration patients: the NAT2 study","volume":"10","author":"Merle","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.107894_bib73","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ophtha.2018.08.006","article-title":"Mediterranean diet and incidence of advanced age-related macular degeneration: the EYE-RISK consortium","volume":"126","author":"Merle","year":"2019","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib74","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jamaophthalmol.2015.2715","article-title":"Association between vitamin D status and age-related macular degeneration by genetic risk","volume":"133","author":"Millen","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib75","first-page":"5027","article-title":"Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population","volume":"25","author":"Momozawa","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib76","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ophtha.2009.10.001","article-title":"Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population","volume":"117","author":"Mori","year":"2010","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib77","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/1479-7364-5-6-538","article-title":"Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration","volume":"5","author":"Morrison","year":"2011","journal-title":"Hum. Genom."},{"key":"10.1016\/j.exer.2019.107894_bib78","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2018.10.037","article-title":"The ARMS2 A69S polymorphism is associated with delayed rod-mediated dark adaptation in eyes at risk for incident age-related macular degeneration","volume":"126","author":"Mullins","year":"2019","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib79","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.ophtha.2010.12.011","article-title":"Genetic variants in pigment epithelium-derived factor influence response of polypoidal choroidal vasculopathy to photodynamic therapy","volume":"118","author":"Nakata","year":"2011","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib80","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1073\/pnas.0912019107","article-title":"Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)","volume":"107","author":"Neale","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2019.107894_bib81","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/IAE.0000000000001454","article-title":"Association between visual function and subretinal drusenoid deposits in normal and early age-related macular degeneration eyes","volume":"37","author":"Neely","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.exer.2019.107894_bib82","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/IAE.0b013e31822a2c7c","article-title":"Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration","volume":"32","author":"Orlin","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.exer.2019.107894_bib83","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1167\/iovs.14-14047","article-title":"FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression","volume":"55","author":"Owen","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib84","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1167\/iovs.15-18962","article-title":"Visual function in older eyes in normal macular health: association with incident early age-related macular degeneration 3 Years later","volume":"57","author":"Owsley","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib85","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/02713683.2015.1011282","article-title":"Comparison of visual function in older eyes in the earliest stages of age-related macular degeneration to those in normal macular health","volume":"41","author":"Owsley","year":"2016","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2019.107894_bib86","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ophtha.2015.09.041","article-title":"Delayed rod-mediated dark adaptation is a functional biomarker for incident early age-related macular degeneration","volume":"123","author":"Owsley","year":"2016","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib87","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10792-016-0391-4","article-title":"A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration","volume":"37","author":"Park","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib88","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12886-017-0631-z","article-title":"Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy","volume":"17","author":"Park","year":"2017","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib89","first-page":"1680","article-title":"Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients","volume":"20","author":"Park","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107894_bib90","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/s41598-019-38919-7","article-title":"Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration","volume":"9","author":"Parmeggiani","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2019.107894_bib91","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajo.2009.09.024","article-title":"Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration","volume":"149","author":"Pauer","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib92","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/j.ophtha.2015.01.031","article-title":"Re: Chew et al.: genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test? (Ophthalmology 2015;122:212-215)","volume":"122","author":"Pearlman","year":"2015","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib93","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ajo.2011.05.016","article-title":"Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study","volume":"152","author":"Peter","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib94","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ophtha.2017.10.027","article-title":"Association of rare predicted loss-of-function variants in cellular pathways with sub-phenotypes in age-related macular degeneration","volume":"125","author":"Pietraszkiewicz","year":"2018","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib95","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1093\/hmg\/ddu276","article-title":"Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration","volume":"23","author":"Ratnapriya","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib96","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ng.976","article-title":"A rare penetrant mutation in CFH confers high risk of age-related macular degeneration","volume":"43","author":"Raychaudhuri","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib97","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1167\/iovs.14-14246","article-title":"Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study","volume":"55","author":"Restrepo","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib98","first-page":"4532","article-title":"Lipid biomarker and hepatic lipase (LIPC) gene associations with age-related macular degeneration","volume":"51","author":"Reynolds","year":"2010","journal-title":"ARVO Meeting Abstracts"},{"key":"10.1016\/j.exer.2019.107894_bib99","doi-asserted-by":"crossref","first-page":"37924","DOI":"10.1038\/srep37924","article-title":"GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration","volume":"6","author":"Riaz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2019.107894_bib100","first-page":"79","article-title":"Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent","volume":"25","author":"Rohrer","year":"2019","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107894_bib101","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/1060028016680643","article-title":"Benefits, potential harms, and optimal use of nutritional supplementation for preventing progression of age-related macular degeneration","volume":"51","author":"Rojas-Fernandez","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.exer.2019.107894_bib102","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-3-319-17121-0_14","article-title":"Gene-diet interactions in age-related macular degeneration","volume":"854","author":"Rowan","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.exer.2019.107894_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005508","article-title":"Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration","volume":"4","author":"SanGiovanni","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.107894_bib104","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000193002","article-title":"Variation in lipid-associated genes as they relate to risk of advanced age-related macular degeneration","volume":"99","author":"SanGiovanni","year":"2009","journal-title":"World Rev. Nutr. Diet."},{"key":"10.1016\/j.exer.2019.107894_bib105","first-page":"1062","article-title":"Whole exome sequencing of extreme age-related macular degeneration phenotypes","volume":"22","author":"Sardell","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107894_bib106","doi-asserted-by":"crossref","first-page":"AMD65","DOI":"10.1167\/iovs.17-23764","article-title":"Patterns of fundus autofluorescence lifetimes in eyes of individuals with nonexudative age-related macular degeneration","volume":"59","author":"Sauer","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib107","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/archophthalmol.2010.261","article-title":"Prospective study of common variants in the retinoic acid receptor-related orphan receptor alpha gene and risk of neovascular age-related macular degeneration","volume":"128","author":"Schaumberg","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib108","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archopht.125.1.55","article-title":"A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors","volume":"125","author":"Schaumberg","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib109","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/375500","article-title":"A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study","volume":"72","author":"Schick","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1515\/BMT.2005.038","article-title":"[Limits of the confocal laser-scanning technique in measurements of time-resolved autofluorescence of the eye-ground]","volume":"50","author":"Schweitzer","year":"2005","journal-title":"Biomed. Tech."},{"key":"10.1016\/j.exer.2019.107894_bib111","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archopht.123.6.774","article-title":"Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers","volume":"123","author":"Seddon","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib112","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1167\/iovs.08-3064","article-title":"Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables","volume":"50","author":"Seddon","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib113","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1167\/iovs.08-2514","article-title":"Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies","volume":"50","author":"Seddon","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib114","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.ophtha.2011.04.029","article-title":"Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors","volume":"118","author":"Seddon","year":"2011","journal-title":"Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/378505","article-title":"A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions","volume":"73","author":"Seddon","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib116","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2016-308624","article-title":"Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis","volume":"100","author":"Seddon","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib117","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.1996.03540140029022","article-title":"A prospective study of cigarette smoking and age-related macular degeneration in women [see comments]","volume":"276","author":"Seddon","year":"1996","journal-title":"Jama"},{"key":"10.1016\/j.exer.2019.107894_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2015.11.033","article-title":"Predictors of response to intravitreal anti-vascular endothelial growth factor treatment of age-related macular degeneration","volume":"163","author":"Shah","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib119","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.visres.2009.09.016","article-title":"Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach","volume":"50","author":"Silveira","year":"2010","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2019.107894_bib120","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/hmg\/ddm146","article-title":"Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration","volume":"16","author":"Spencer","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib121","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.12659\/MSM.893697","article-title":"Serum MicroRNAs as potential biomarkers of AMD","volume":"21","author":"Szemraj","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.exer.2019.107894_bib122","first-page":"1028","article-title":"Comparison of the efficacy of anti-VEGF monotherapy versus PDT and intravitreal anti-VEGF combination treatment in AMD: a Meta-analysis and systematic review","volume":"9","author":"Tong","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib123","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1167\/iovs.15-17432","article-title":"Rare variants in the functional domains of complement factor H are associated with age-related macular degeneration","volume":"56","author":"Triebwasser","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022959","article-title":"Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components","volume":"6","author":"Vierkotten","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.107894_bib125","doi-asserted-by":"crossref","first-page":"31531","DOI":"10.1038\/srep31531","article-title":"Mapping rare, deleterious mutations in Factor H: association with early onset, drusen burden, and lower antigenic levels in familial AMD","volume":"6","author":"Wagner","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2019.107894_bib126","doi-asserted-by":"crossref","first-page":"15711","DOI":"10.1038\/srep15711","article-title":"CETP\/LPL\/LIPC gene polymorphisms and susceptibility to age-related macular degeneration","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2019.107894_bib127","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/eye.2015.204","article-title":"A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration","volume":"30","author":"Warwick","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.exer.2019.107894_bib128","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9394(01)01214-4","article-title":"Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions","volume":"132","author":"Weeks","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/422476","article-title":"Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions","volume":"75","author":"Weeks","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib130","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/bjophthalmol-2016-309418","article-title":"Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: a meta-analysis","volume":"101","author":"Wu","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107894_bib131","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1167\/iovs.11-8205","article-title":"Association of elastin gene polymorphism to age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"52","author":"Yamashiro","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib132","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/hmg\/ddy002","article-title":"Genome-wide analysis of disease progression in age-related macular degeneration","volume":"27","author":"Yan","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib133","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1167\/iovs.08-3202","article-title":"Expression and modulation of RPE cell membrane complement regulatory proteins","volume":"50","author":"Yang","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107894_bib134","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exer.2019.107894_bib135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2019.107894_bib136","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/hmg\/ddr270","article-title":"Common variants near FRK\/COL10A1 and VEGFA are associated with advanced age-related macular degeneration","volume":"20","author":"Yu","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib137","first-page":"5276","article-title":"Protective coding variants in CFH and PELI3 and a variant near CTRB1 are associated with age-related macular degenerationdagger","volume":"25","author":"Yu","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2019.107894_bib138","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2174\/15665240113139990048","article-title":"Common variant in VEGFA and response to anti-VEGF therapy for neovascular age-related macular degeneration","volume":"13","author":"Zhao","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.exer.2019.107894_bib139","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12886-017-0487-2","article-title":"Association between polymorphism rs11200638 in the HTRA1 gene and the response to anti-VEGF treatment of exudative AMD: a meta-analysis","volume":"17","author":"Zhou","year":"2017","journal-title":"BMC Ophthalmol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519304816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519304816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:02:56Z","timestamp":1757998976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483519304816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":139,"alternative-id":["S0014483519304816"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.107894","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive genetics for AMD: Hype and hopes for genetics-based strategies for treatment and prevention","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.107894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107894"}}